Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine
First results from any randomised, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6 per…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pfizer-BioNTech vaccine
Vaccines offer strong protection against death from COVID-19 Delta variant
The research, involving the University of Strathclyde, has found that the Pfizer-BioNTech vaccine is 90 per cent effective and the…
NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease
Trial also will test pausing immunosuppressive medication to improve antibody response
BioNTech says repeats of its COVID-19 vaccine better than devising new one, for now
The German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns…
Israel reports decrease in Pfizer vaccine effectiveness against infections
The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel
Delta variant double risk of hospitalisation but vaccine provides protection: Study
Vaccines were found to reduce the risk of being admitted to hospital, but strong protective effects against the Delta variant were…
Two AstraZeneca COVID shots 85-90 per cent effective, says UK real-world analysis
Britain has suffered one of the worst death tolls globally from the pandemic, but has also had one of the fastest vaccine…
Pfizer in talks with India over expedited approval for COVID-19 vaccine
Albert Bourla, CEO, Pfizer also announced a donation of medicines worth more than $70 million
New Zealand approves COVID-19 vaccine, warns against nationalism
rime Minister Jacinda Ardern said she still expected supplies of the Pfizer-BioNTech product to arrive in the country by…